Allopurinol enhances the activity of hypoxanthine-guanine phosphoribosyltransferase in inflammatory bowel disease patients during low-dose thiopurine therapy: Preliminary data of an ongoing series

Nucleosides, Nucleotides and Nucleic Acids

Volumn 30, Issue 12, 2011, Pages 1085-1090

  Seinen, Margien L ^a   De Boer, Nanne K H ^a   Smid, Kees ^b   Van Asseldonk, Dirk P ^a   Bouma, Gerd ^a   Van Bodegraven, Adriaan A ^a   Peters, Godefridus J ^b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Allopurinol; Azathioprine; Hypoxanthine guanine phosphoribosyltransferase; Inflammatory bowel disease; Mercaptopurine

Indexed keywords

ALLOPURINOL; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MERCAPTOPURINE; NUCLEOTIDE; THIOGUANINE NUCLEOTIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; ENTERITIS; ENZYME ACTIVITY; ENZYME METABOLISM; ERYTHROCYTE; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MONOTHERAPY; NUCLEOTIDE METABOLISM; SCHOOL CHILD;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; ALLOPURINOL; AZATHIOPRINE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GOUT SUPPRESSANTS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84855872040     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2011.597371     Document Type: Article

References (16)

1. Almer, S. Novel strategies in the thiopurine treatment of inflammatory bowel disease. Nucleosides Nucleotides Nucleic Acids 2010, 29(4-6), 267-277.
2. Pearson, D. C.; May, G. R.; Fick, G.; Sutherland, L. R. Azathioprine for maintaining remission of Crohn's disease. Cochrane Database Syst. Rev. 2000, (2), CD000067.
3. Timmer, A.; McDonald, J. W.; Macdonald, J. K. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst. Rev. 2007, (1), CD000478.
4. Cuffari, C.; Theoret, Y.; Latour, S.; Seidman, G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut 1996, 39(3), 401-406. (Pubitemid 26338529)
5. Dubinsky, M. C.; Yang, H.; Hassard, P. V.; Seidman, E. G.; Kam, L. Y.; Abreu, M. T.; Targan, S. R.; Vasiliauskas, E. A. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology 2002, 122(4), 904-915. (Pubitemid 34267273)
6. Sparrow, M. P.; Hande, S. A.; Friedman, S.; Lim, W. C.; Reddy, S. I.; Cao, D.; Hanauer, S. B. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment. Pharmacol. Ther. 2005, 22(5), 441-446. (Pubitemid 41248111)
7. Sparrow, M. P.; Hande, S. A.; Friedman, S.; Cao, D.; Hanauer, S. B. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine. Clin. Gastroenterol. Hepatol. 2007, 5(2), 209-214. (Pubitemid 46216945)
8. Ansari, A.; Elliott, T.; Baburajan, B.; Mayhead, P.; O'Donohue, J.; Chocair, P.; Sanderson, J.; Duley, J. Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease. Aliment. Pharmacol. Ther. 2008, 28(6), 734-741.
9. de Graaf, P.; Vos, R. M.; de Boer, N. H.; Sinjewel, A.; Jharap, B.; Mulder, C. J.; van Bodegraven, A. A.; Veldkamp, A. I. Limited stability of thiopurine metabolites in blood samples: relevant in research and clinical practise. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878(19), 1437-1442.
10. Dervieux, T.; Boulieu, R. Identification of 6-methylmercaptopurine derivative formed during acid hydrolysisofthiopurine nucleotides in erythrocytes, using liquid chromatography-mass spectrometry, infrared spectroscopy, and nuclear magnetic resonance assay. Clin. Chem. 1998, 44(12), 2511-2515. (Pubitemid 28565664)
11. Tax, W. J.; Veerkamp, J. H.; Trijbels, J. M. Activity of purine phosphoribosyltransferases and of two enzymes of pyrimidine biosynthesis in erythrocytes of ten mammalian species. Comp. Biochem. Physiol. B 1976, 54(2), 209-212.
12. Peters, G. J.; Veerkamp, J. H. Concentration, synthesis and utilization of phosphoribosylpyrophosphate in lymphocytes of five mammalian species. Int. J. Biochem. 1979, 10(11), 885-888.
13. van Asseldonk, D. P.; de Boer, N. K.; Smid, K.; Mulder, C. J.; van Bodegraven, A. A.; Peters, G. J. Limited intra-individual variability in hypoxanthine-guanine phosphoribosyl transferase, thiopurine S-methyl transferase, and xanthine oxidase activity in inflammatory bowel disease patients during 6-thioguanine therapy. Nucleosides Nucleotides Nucleic Acids 2010, 29(4-6), 284-290.
14. Gardiner, S. J.; Gearry, R. B.; Burt, M. J.; Chalmers-Watson, T.; Chapman, B. A.; Ross, A. G.; Stedman, C. A.; Huelsen, A.; Barclay, M. L. Allopurinol might improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio. J. Gastroenterol. Hepatol. 2011, 26(1), 49-54.
15. Duley, J. A.; Chocair, P. R.; Florin, T. H. Observations on the use of allopurinol in combination with azathioprine or mercaptopurine. Aliment. Pharmacol. Ther. 2005, 22(11-12), 1161-1162. (Pubitemid 41779525)
16. Ding, L.; Zhang, F. B.; Liu, H.; Gao, X.; Bi, H. C.; Wang, X. D.; Chen, B. L.; Zhang, Y.; Zhao, L. Z.; Zhong, G. P.; Hu, P. J.; Chen, M. H.; Huang, M.; Hypoxanthine guanine phosphoribosyltransferase activity is related to 6-thioguanine nucleotide concentrations and thiopurine-induced leukopenia in the treatment of inflammatory bowel disease. Inflamm. Bowel Dis. 2011, Mar. 4, [Epub ahead of print].